[go: up one dir, main page]

RS49832B - Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijanje jedinjenja i upotreba ovih jedinjenja - Google Patents

Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijanje jedinjenja i upotreba ovih jedinjenja

Info

Publication number
RS49832B
RS49832B YUP-15/00A YU1500A RS49832B RS 49832 B RS49832 B RS 49832B YU 1500 A YU1500 A YU 1500A RS 49832 B RS49832 B RS 49832B
Authority
RS
Serbia
Prior art keywords
sajd
compounds
alkyloxy
preparing
furanone derivatives
Prior art date
Application number
YUP-15/00A
Other languages
English (en)
Inventor
Raphael BOUCHET
Francis BRlON
Colette COLLADANT
Jacques AGOUARDAT
Original Assignee
Aventis Pharma S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A., filed Critical Aventis Pharma S.A.,
Publication of YU1500A publication Critical patent/YU1500A/sh
Publication of RS49832B publication Critical patent/RS49832B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60—Two oxygen atoms, e.g. succinic anhydride
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Jedinjenja formula (IVa) (IVb), (IVc) ili (IVd) koje slede: gde je R1, alkil grupa koja sadrži od 1 do 4 atoma ugljenika ili fenilalkil grupa koja sadrži od 7 do 11 atoma ugljenika, kao i njihove adicione soli sa kiselinama. Prijava sadrži još 18 patentnih zahteva.
YUP-15/00A 1997-07-15 1998-07-09 Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijanje jedinjenja i upotreba ovih jedinjenja RS49832B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9708932A FR2766188B1 (fr) 1997-07-15 1997-07-15 Nouveau procede de preparation de derives amines d'alkyloxy furanone, composes issus de ce procede et utilisation de ces composes

Publications (2)

Publication Number Publication Date
YU1500A YU1500A (sh) 2002-10-18
RS49832B true RS49832B (sr) 2008-08-07

Family

ID=9509210

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-15/00A RS49832B (sr) 1997-07-15 1998-07-09 Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijanje jedinjenja i upotreba ovih jedinjenja

Country Status (34)

Country Link
US (1) US6235899B1 (sr)
EP (1) EP0998470B1 (sr)
JP (1) JP4450987B2 (sr)
KR (1) KR100519691B1 (sr)
CN (1) CN100363355C (sr)
AP (1) AP1071A (sr)
AR (1) AR015924A1 (sr)
AT (1) ATE239713T1 (sr)
AU (1) AU744272B2 (sr)
BG (1) BG64050B1 (sr)
BR (1) BR9810896A (sr)
CA (1) CA2296742C (sr)
CZ (1) CZ295312B6 (sr)
DE (1) DE69814395T2 (sr)
DK (1) DK0998470T3 (sr)
EA (1) EA002883B1 (sr)
EE (1) EE03873B1 (sr)
ES (1) ES2197489T3 (sr)
FR (1) FR2766188B1 (sr)
HR (1) HRP20000027B1 (sr)
HU (1) HU230148B1 (sr)
ID (1) ID23784A (sr)
IL (1) IL134031A (sr)
ME (1) ME01708B (sr)
NO (1) NO324508B1 (sr)
NZ (1) NZ502338A (sr)
PL (1) PL200820B1 (sr)
PT (1) PT998470E (sr)
RS (1) RS49832B (sr)
SK (1) SK284168B6 (sr)
TR (1) TR200000117T2 (sr)
UA (1) UA66364C2 (sr)
WO (1) WO1999003852A1 (sr)
ZA (1) ZA986203B (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053056B2 (en) * 1998-07-02 2006-05-30 Idun Pharmaceuticals, Inc. C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
EP1278737B1 (en) * 2000-04-24 2010-06-30 Vertex Pharmaceuticals Incorporated Process and intermediates for making substituted aspartic acid acetals
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
JP2003327568A (ja) * 2000-09-20 2003-11-19 Kanegafuchi Chem Ind Co Ltd 光学活性β−アミノ酸誘導体の製造方法
JPWO2002055478A1 (ja) * 2001-01-16 2004-05-13 鐘淵化学工業株式会社 光学活性アミノラクトン誘導体の製造法およびその中間体
JP2007525503A (ja) 2004-02-27 2007-09-06 バーテックス　ファーマシューティカルズ　インコーポレイテッド カスパーゼインヒビターおよびそれらの使用
DK2399916T3 (en) 2004-03-12 2015-03-02 Vertex Pharma A process and intermediates for the preparation of asparaginacetal-caspase inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5716929A (en) * 1994-06-17 1998-02-10 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme

Also Published As

Publication number Publication date
PT998470E (pt) 2003-09-30
BG64050B1 (bg) 2003-11-28
ATE239713T1 (de) 2003-05-15
DE69814395D1 (de) 2003-06-12
AU8633398A (en) 1999-02-10
UA66364C2 (uk) 2004-05-17
CZ200065A3 (cs) 2000-07-12
JP4450987B2 (ja) 2010-04-14
AP2000001732A0 (en) 2000-03-31
NO20000182L (no) 2000-03-07
CN100363355C (zh) 2008-01-23
EA002883B1 (ru) 2002-10-31
EP0998470A1 (fr) 2000-05-10
IL134031A (en) 2004-06-01
BG104073A (en) 2001-05-31
EE03873B1 (et) 2002-10-15
KR100519691B1 (ko) 2005-10-13
YU1500A (sh) 2002-10-18
DE69814395T2 (de) 2003-12-11
ZA986203B (en) 1999-08-18
EA200000127A1 (ru) 2000-08-28
AR015924A1 (es) 2001-05-30
NZ502338A (en) 2001-09-28
HUP0003857A2 (hu) 2001-04-28
HRP20000027B1 (en) 2006-07-31
DK0998470T3 (da) 2003-09-01
FR2766188B1 (fr) 2000-02-11
TR200000117T2 (tr) 2000-07-21
EE200000024A (et) 2000-10-16
JP2001510191A (ja) 2001-07-31
CN1269795A (zh) 2000-10-11
HUP0003857A3 (en) 2002-08-28
AU744272B2 (en) 2002-02-21
US6235899B1 (en) 2001-05-22
PL338035A1 (en) 2000-09-25
ES2197489T3 (es) 2004-01-01
SK302000A3 (en) 2000-11-07
BR9810896A (pt) 2000-09-26
HU230148B1 (hu) 2015-09-28
CA2296742C (fr) 2009-12-08
CA2296742A1 (fr) 1999-01-28
FR2766188A1 (fr) 1999-01-22
WO1999003852A1 (fr) 1999-01-28
SK284168B6 (sk) 2004-10-05
CZ295312B6 (cs) 2005-07-13
KR20010021834A (ko) 2001-03-15
EP0998470B1 (fr) 2003-05-07
AP1071A (en) 2002-05-20
IL134031A0 (en) 2001-04-30
NO20000182D0 (no) 2000-01-14
NO324508B1 (no) 2007-11-05
ME01708B (me) 2008-08-07
HRP20000027A2 (en) 2000-10-31
PL200820B1 (pl) 2009-02-27
ID23784A (id) 2000-05-11

Similar Documents

Publication Publication Date Title
ATE215078T1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
WO2003039451A3 (en) Thiazole pyridazinones as adenosine antagonists
PL328726A1 (en) Novel tricycle compounds, method of obtaining them and their applications
YU49122B (sh) Supstituisana benzilaminopiperidinska jedinjenja
YU47099B (sh) Postupak za dobijanje makrolidnih jedinjenja
DE50100893D1 (de) Verfahren zur Herstellung von 3,4-Alkylendioxythiophen-2,5-dicarbonsäurederivaten
ATE200286T1 (de) Chinolincarbonsäure-derivate
YU46547B (sh) 1,4-dihidropiridini i postupak za njihovo dobijanje
PE34996A1 (es) Nuevo derivado de pirrocarbazol
RS49587B (sr) Novi postupak za dobijanje pesticidnih intermedijera
RS49832B (sr) Postupak za dobijanje aminskih derivata alkiloksifuranona, dobijanje jedinjenja i upotreba ovih jedinjenja
EG15346A (en) Novel arylamine derivatives,production thereof and use thereof as microbicides
FI940731A (fi) Amiditetratsolit ACAT-inhibiitoreina
ATE50773T1 (de) Alkylresorcinolphosphite.
ES2065994T3 (es) Beta-dicetonas substituidas.
ATE37872T1 (de) Phenylinden-derivate, ihre salze, und verfahren zu ihrer herstellung.
RS49829B (sr) Postupak i intermedijeri za proizvodnju piridin-2,3-dikarboksilat jedinjenja
BG103398A (en) New derivatives of erythromicyn, method for their preparation and application as medicmentous forms
ATE97404T1 (de) Prostazyklin-(pgi2)-analoge.
ES2144327T3 (es) Procedimiento para preparar un compuesto de 2-cianobifenilo.
ATE151750T1 (de) 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind
AU6595000A (en) Dihydrobenzofuran derivatives, process for the preparation thereof and agents
SE8703494D0 (sv) Mellanprodukter anvendbara vid framstellning av 2-tiofen-ettiksyraderivat
EA199800931A1 (ru) Способ получения ингибиторов фосфодиэстеразы iv
IL125873A (en) 1(2h) quinoline carboxylic acid derivatives, method for preparing same, and use thereof for synthesising substances having antibiotic properites